Related Experiment Video
Updated: May 20, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Future of chronic obstructive pulmonary disease management
Anthony D'Urzo1, Claus Vogelmeier
1Department of Family and Community Medicine, University of Toronto, ON, Canada. tonydurzo@sympatico.ca
Expert Review of Respiratory Medicine
|July 14, 2012
Summary
Short-acting bronchodilators offer immediate symptom relief for chronic obstructive pulmonary disease (COPD). Long-acting bronchodilators are key for maintenance therapy, and combining different types may improve symptom control in COPD management.
Area of Science:
- Pulmonary Medicine
- Pharmacology
Background:
- Bronchodilators are essential for managing symptomatic chronic obstructive pulmonary disease (COPD).
- Short-acting bronchodilators provide rapid symptom relief across all COPD stages.
- Long-acting bronchodilators are recommended for maintenance therapy in moderate-to-very severe COPD with daily symptoms.
Purpose of the Study:
- To review the role of bronchodilators in COPD management.
- To discuss the potential benefits of combining different bronchodilator classes.
- To highlight emerging long-acting bronchodilator therapies.
Main Methods:
- Literature review of current bronchodilator use in COPD.
- Analysis of treatment guidelines for COPD symptom management.
- Overview of ongoing research and development in long-acting bronchodilators.
Main Results:
- Inhaled short-acting bronchodilators are used for immediate symptom relief in all COPD stages.
- Long-acting bronchodilators are recommended for maintenance in moderate-to-very severe COPD with daily symptoms.
- Combining different bronchodilator classes may be effective when monotherapy is insufficient.
Conclusions:
- Bronchodilators are central to COPD symptom management.
- New long-acting bronchodilators and combination inhalers are under development.
- Future treatment algorithms will depend on the efficacy, safety, and long-term outcomes of these new agents.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...